Which of the following is NOT an advantage of low molecular weight heparin over unfractionated heparin ?: (A) Higher efficacy in arterial thrombosis, (B) Less frequent dosing, (C) Higher and more consistent subcutaneous bioavailability, (D) Laboratory monitoring of response not required
Answer is A. None